Fonte: Polymers. Unidades: IFSC, FM
Assuntos: DOR CRÔNICA, BIOMEDICINA, NANOTECNOLOGIA, TOXICOLOGIA
ABNT
RODRIGUES, Rafaela Figueiredo et al. Preclinical evaluation of polymeric nanocomposite containing pregabalin for sustained release as potential therapy for neuropathic pain. Polymers, v. No 2021, n. 21, p. 3837-1-3837-20, 2021Tradução . . Disponível em: https://doi.org/10.3390/polym13213837. Acesso em: 22 ago. 2024.APA
Rodrigues, R. F., Nunes, J. B., Agostini, S. B. N., Santos, P. F. dos, Cancino-Bernardi, J., Placido, R. V., et al. (2021). Preclinical evaluation of polymeric nanocomposite containing pregabalin for sustained release as potential therapy for neuropathic pain. Polymers, No 2021( 21), 3837-1-3837-20. doi:10.3390/polym13213837NLM
Rodrigues RF, Nunes JB, Agostini SBN, Santos PF dos, Cancino-Bernardi J, Placido RV, Moraes TR, Freitas JTJ, Pereira GR, Carvalho FC, Galdino G, Boralli VB. Preclinical evaluation of polymeric nanocomposite containing pregabalin for sustained release as potential therapy for neuropathic pain [Internet]. Polymers. 2021 ; No 2021( 21): 3837-1-3837-20.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3390/polym13213837Vancouver
Rodrigues RF, Nunes JB, Agostini SBN, Santos PF dos, Cancino-Bernardi J, Placido RV, Moraes TR, Freitas JTJ, Pereira GR, Carvalho FC, Galdino G, Boralli VB. Preclinical evaluation of polymeric nanocomposite containing pregabalin for sustained release as potential therapy for neuropathic pain [Internet]. Polymers. 2021 ; No 2021( 21): 3837-1-3837-20.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3390/polym13213837